Psoriasis Research Today is a free monthly online journal that collates and summarizes the latest research about Psoriasis, including details on treatment, prevention, medication, causes.

Volume 5 (2008), Issue 5 (May)

1. Psoriasis and vascular disease: an unsolved mystery.
   Am J Med, 121(5): 360-5. [Abstract] [Full-text]
2. A systematic review and meta-analysis of efficacy and toxicity of disease modifying anti-rheumatic drugs and biological agents for psoriatic arthritis.
   Ann Rheum Dis, 67(6): 855-9. [Abstract] [Full-text]
3. Efficacy and safety of ustekinumab, a human interleukin-12/23 monoclonal antibody, in patients with psoriasis: 52-week results from a randomised, double-blind, placebo-controlled trial (PHOENIX 2).
   Lancet, 371(9625): 1675-84. [Abstract] [Full-text]
4. Efficacy and safety of ustekinumab, a human interleukin-12/23 monoclonal antibody, in patients with psoriasis: 76-week results from a randomised, double-blind, placebo-controlled trial (PHOENIX 1).
   Lancet, 371(9625): 1665-74. [Abstract] [Full-text]
5. Frequency and duration of clinical remission in patients with peripheral psoriatic arthritis requiring second-line drugs.
   Rheumatology (Oxford), 47(6): 872-6. [Abstract] [Full-text]
6. Measuring clinical enthesitis in psoriatic arthritis: assessment of existing measures and development of an instrument specific to psoriatic arthritis.
   Arthritis Rheum, 59(5): 686-91. [Abstract] [Full-text]

© 2004-2008 Psoriasis Research Today. All Rights Reserved.